"Pharma Industry Research Method Business Strategy"
Brochure More information from http://www.researchandmarkets.com/reports/452447/ Executing Change in the Pharma Industry - Prescription for Pfizer Description: Pharmaceutical history is littered with the abandoned husks of great ideas, many costing a king’s ransom and never able to live up to their promise. Indeed, there is little doubt that in recent years pharmaceutical companies have been getting their execution wrong. The key to future survival and success is a company’s willingness to embrace change and adopt new approaches to execution. Pfizer’s recent implosion speaks to the heart of the challenges facing the pharmaceutical industry today. Dynamic changes are under way in this industry, and downsizing alone is unlikely to be enough to save many companies. This report suggests several changes to both strategy and execution that will help companies be viable in tomorrow’s marketplace. While there are both challenges to overcome and pitfalls to avoid along the way, getting execution right now matters more than ever. Get the Answers You Need to Shape Your Strategy There is little doubt that in recent years, pharmaceutical companies have been getting their execution wrong. What mistakes have been made and how can companies correct their execution of strategic goals? The cost structure of today’s pharmaceutical industry has changed. What procedures will improve effectiveness in this new business environment? A number of valuable opportunities for change exist for pharmaceutical management. What are they, and how will they affect the success of the industry? There are major impediments to change in the pharmaceutical industry. What are they, and how can they be overcome? Scope -Basic concepts affecting and impeding company change: corporate culture, strategy versus execution, behavior versus attitude, efficiency versus effectiveness. -Pfizer: victim of its own success and prescription for change. -Prescriptive plans for Pharma: simple strategies to improve execution of strategic goals. -Cost-cutting: a vicious cycle of long-term, negative effects from short-term solutions. -Marketing & selling: optimizing direct-to-consumer advertising and sales force size. -Lipitor: useful as a litmus test for the impact of promotion on sales in the current market. -Outsourcing and off shoring: cost-efficiencies that create tomorrow’s competition. Contents: Executive Summary Strategic Considerations Stakeholder Implications Companies Have Been Getting Execution Wrong Basic Concepts Strategy and Execution Behavior Attitude Strategy-Execution Disconnect A Vicious Cycle Arises from Shedding Employees to Cut Costs Knowledge/Organizational Size Disconnect Efficiency Effectiveness Marketing & Selling Efficiency and Effectiveness in Pharmaceutical R&D Wars of Attrition over Sales forces Direct-to-Consumer (DTC) Getting Execution Right Now Matters More Than Ever Prescription for Pfizer Pfizer in a Nutshell Falling on Your Sword Victim of Its Own Success Look Beyond Simplistic Downsizing Pfizer’s Current Predicament Lipitor as a Litmus Test for the Impact of Promotion on Sales Pfizer’s Pipeline Progress Pressure to Find Sufficient New Products Corporate Size Limits Available Targets for Development Increased Product Opportunities for Smaller Companies What Pharmaceutical Companies Can Learn from Pfizer’s Current Predicament Five Quick Wins for Pharma Downsizing the Sales force Changing the Focus of DTC Promotion Zero-Based Budgeting Return-on-Investment (ROI) Cultural Audit The Bottom Line The Curse of the Margin The False Prophets of Outsourcing and Offshoring Ordering: Order Online - http://www.researchandmarkets.com/reports/452447/ Order by Fax - using the form below Order by Post - print the order form below and sent to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland. Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607- 1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit http://www.researchandmarkets.com/contact/ Order Information Please verify that the product information is correct. Product Name: Executing Change in the Pharma Industry - Prescription for Pfizer Web Address: http://www.researchandmarkets.com/reports/452447/ Office Code: OC8HPMLNONQQS Product Format Please select the product format and quantity you require: Quantity Electronic: EURO €765.00 Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: Last Name: Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL) Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: American Express Diners Club Master Card Visa Cardholder's Name Cardholder's Signature Expiry Date Card Number CVV Number Issue Date (for Diners Club only) Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Please transfer funds to: Pay by wire transfer: Account number 833 130 83 Sort code 98-53-30 Swift code ULSBIE2D IBAN number IE78ULSB98533083313083 Bank Address Ulster Bank, 27-35 Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353 1 481 1716 or +353 1 653 1571 - From Rest of World